Canada John London, CEO at Nuvo Pharmaceuticals Inc., explains how he and his partners turned the Canadian company from insolvency into a profitable enterprise with FDA approved products that are being marketed around the world. He further talks opportunities in the topical pain management market and how Nuvo Pharmaceuticals will enhance…
Taiwan Chin Chun Lin, chairman of Taiwan Leader Biotech Corp., discusses the importance of herbal medicine for preventive healthcare, and shares valuable insights into Taiwan Leader Biotech Corp., a leading company in medicinal fungus, that established brand recognition through balancing social, economic and environmental perspectives while promoting the importance of the…
Switzerland With a recent clinical trial showing one of Bioforce’s Echinacea products to be non-inferior to the gold standard allopathic treatment Tamiflu, CEO Peter Gmünder is working to continue the work of Swiss phytopharmaceuticals pioneer Alfred Vogel by providing the highest quality natural remedies made using only fresh herbs if possible.…
Pharma Do phenomenons such as Brexit and the Trump election victory mean trouble for the pharma industry or are you more optimistic? Take the PharmaBoardroom poll on the pharma industry in 2017 and stay tuned for the results! Create your own user feedback survey
Taiwan Howard Lee, chairman and CEO of Easywell Biomedicals, documents the most exciting R&D projects that will drive the company to new heights; spanning from a life-changing Parkinson’s transdermal patch to a ground-breaking regenerative therapy in advanced wound care. Easywell was recently ranked the tenth fastest-growing high-tech company in Taiwan by…
Singapore Pierre Fabre Medicament’s MD for Asia Pacific, Ng Tian Wee, on the growing importance of the region for PF, the significance of choosing Singapore as a regional hub, and the company’s strategy moving forward. In a few words, what is Pierre Fabre’s set up and mandate? The company is owned…
Switzerland Not all impactful innovation involves the development of new chemical or biological entities, and the value of such innovation must be recognized in pricing processes argues Gebro Pharma Switzerland CEO Marcel Plattner. We understand you serve as the head of the executive committee for market access and pricing within the…
Taiwan Kao Su-Chin Chang, founder and chairman of Weidar Chemical and Pharmaceutical, describes the robust development and international expansion of this historical domestic pharmaceutical manufacturer and the company’s enduring commitment to maintaining the excellence of its manufacturing capacity, which has allowed Weidar to establish itself as one of the foremost generics…
Ireland Barry Joyce, MD at VWR Ireland, takes us through the priorities of the first few months of his appointment, the strategic position of VWR in Ireland and within the global VWR (NASDAQ: VWR) organization, the importance of taking a partnership approach with clients instead of a transactional one, and his…
Ireland The strong flow of FDI into Ireland has led to a vibrant ecosystem of Irish service providers, who have grown up servicing the needs of pharma MNCs. Working for FDI clients has put Irish companies to the test and pushed them to work to the highest standards. “Top global pharma…
Mexico Ricardo Amtmann, President at Laboratorios Sanfer, explains how they have grown their business by 100 percent throughout the last three years and showcases the added value of Sanfer to patients in Mexico and internationally by offering high quality drugs and boosting the sales of in-licensed medicines. Could you introduce yourself…
Switzerland Frederic Bengold, MD of Servier Switzerland, on the affiliate’s main growth drivers, an exciting collaboration with Novartis on heart failure medication, and the intricacies of market access in Switzerland. Could you please start by introducing Servier’s Swiss affiliate? We enjoy a longstanding presence and reputation in Switzerland. The local affiliate…
See our Cookie Privacy Policy Here